Strax

Autospela

Exploring the Impact of Anti-PD-1 and Anti-PD-L1 Agents in Merkel Cell Carcinoma

3 Visningar • 07/17/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Suzanne L. Topalian, MD, director, Melanoma Program, professor of Surgery, Johns Hopkins Medicine, discusses the impact of anti-PD-1 and anti-PD-L1 agents in the treatment of merkel cell carcinoma.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela